Recombinant Human PNR Protein，His & GST

PNR (Peroxisome Proliferator-Activated Receptor Nucleotide) is a crucial member of the nuclear receptor superfamily, playing a significant role in regulating gene expression involved in various physiological processes, including metabolism, inflammation, and cell differentiation. Research has shown that PNR is activated by specific ligands, leading to the modulation of target genes related to lipid metabolism and energy homeostasis. Given the increasing prevalence of metabolic disorders such as obesity and diabetes, PNR has garnered attention as a potential therapeutic target. Studies have demonstrated that PNR is implicated in the regulation of adipogenesis and insulin sensitivity, suggesting its critical role in maintaining metabolic health. Additionally, PNR's involvement in inflammatory responses has prompted investigations into its potential in managing chronic inflammatory diseases. Understanding the mechanisms of PNR activation and its downstream effects at the molecular level can provide insights into innovative treatment strategies. Efforts to engineer recombinant PNR proteins have advanced our knowledge of its structure-function relationships, allowing for the exploration of selective PNR modulators that could enhance therapeutic efficacy while minimizing side effects. This ongoing research holds promise for developing new pharmacological agents targeting PNR, ultimately contributing to better management of metabolic and inflammatory diseases.